Why did US miss measles elimination criteria?

US missed measles elimination markers and will reevaluate status

Public health experts declared measles eliminated in the United States in 2000, and the CDC later established seven indicators intended to confirm the country stays on track. A new analysis finds the US missed four of those seven criteria, while the remaining indicators are considered at risk. The country’s measles elimination status is set to be reevaluated in November 2026.

What the findings mean

Measles elimination is not a one-time achievement; it depends on maintaining population-level immunity and on surveillance and outbreak control measures that can prevent sustained transmission. Missing multiple CDC indicators suggests weaknesses in that system—such as the ability to rapidly detect and contain cases, maintain adequate immunity coverage, or prevent outbreaks from gaining traction.

Why it matters now

• Outbreak potential remains real. When surveillance or immunity indicators slip, measles can rebound quickly, especially in communities with gaps in protection.
• Policy and resources can hinge on the status review. A formal reevaluation can drive renewed focus on vaccination delivery, data monitoring, and outbreak response.
• Broader travel and community dynamics raise stakes. Even with national progress, localized gaps can seed outbreaks.

Separately, another report in the pool describes a measles resurgence in Bangladesh after a vaccination breakdown, underscoring that lapses in vaccine procurement or delivery can rapidly translate into hundreds of child deaths.

In the US, the key takeaway is that multiple elimination indicators are not being met, and the CDC’s upcoming review will test whether the country can demonstrate robust control of measles transmission going forward.